These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16369667)
61. [Wound infections due to opportunistic corynebacterium species]. Olender A; Łetowska I Med Dosw Mikrobiol; 2010; 62(2):135-40. PubMed ID: 20873486 [TBL] [Abstract][Full Text] [Related]
62. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Rodríguez-Avial I; Rodríguez-Avial C; Culebras E; Picazo JJ Antimicrob Agents Chemother; 2005 Feb; 49(2):820-3. PubMed ID: 15673778 [TBL] [Abstract][Full Text] [Related]
63. Susceptibility of several macrolides and a ketolide against clinically isolated 'Streptococcus milleri' group. Yamamoto N; Fujita J; Higa F; Tateyama M; Nakasone I; Yamane N Int J Antimicrob Agents; 2006 Mar; 27(3):253-5. PubMed ID: 16472994 [TBL] [Abstract][Full Text] [Related]
65. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Chollet R; Chevalier J; Bryskier A; Pagès JM Antimicrob Agents Chemother; 2004 Sep; 48(9):3621-4. PubMed ID: 15328143 [TBL] [Abstract][Full Text] [Related]
66. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. Mamelli L; Prouzet-Mauléon V; Pagès JM; Mégraud F; Bolla JM J Antimicrob Chemother; 2005 Sep; 56(3):491-7. PubMed ID: 16055509 [TBL] [Abstract][Full Text] [Related]
67. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. El-Mahdy TS; Abdalla S; El-Domany R; Mohamed MS; Ross JI; Snelling AM Anaerobe; 2010 Aug; 16(4):376-9. PubMed ID: 20541615 [TBL] [Abstract][Full Text] [Related]
68. Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics. Fernandes P; Pereira D; Watkins PB; Bertrand D J Med Chem; 2020 Jun; 63(12):6462-6473. PubMed ID: 31644280 [TBL] [Abstract][Full Text] [Related]
69. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. Lagrou K; Verhaegen J; Janssens M; Wauters G; Verbist L Diagn Microbiol Infect Dis; 1998 Jan; 30(1):7-15. PubMed ID: 9488824 [TBL] [Abstract][Full Text] [Related]
70. Characterization of Corynebacterium diphtheriae, C. confusum and C. amycolatum isolated from sows with genitourinary infection. Poor AP; Moreno LZ; Matajira CEC; Parra BM; Gomes VTM; Silva APS; Dutra MC; Christ APG; Barbosa MRF; Sato MIZ; Moreno AM Vet Microbiol; 2017 Aug; 207():149-152. PubMed ID: 28757016 [TBL] [Abstract][Full Text] [Related]
71. Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. Liu M; Douthwaite S Antimicrob Agents Chemother; 2002 Jun; 46(6):1629-33. PubMed ID: 12019067 [TBL] [Abstract][Full Text] [Related]
72. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Zuckerman JM Infect Dis Clin North Am; 2004 Sep; 18(3):621-49, xi-. PubMed ID: 15308279 [TBL] [Abstract][Full Text] [Related]
73. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. Cantón R; Mazzariol A; Morosini MI; Baquero F; Cornaglia G J Antimicrob Chemother; 2005 Apr; 55(4):489-95. PubMed ID: 15705635 [TBL] [Abstract][Full Text] [Related]
74. Streptococcus pneumoniae isolates resistant to telithromycin. Rantala M; Haanperä-Heikkinen M; Lindgren M; Seppälä H; Huovinen P; Jalava J Antimicrob Agents Chemother; 2006 May; 50(5):1855-8. PubMed ID: 16641460 [TBL] [Abstract][Full Text] [Related]
75. Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin. Schmitz FJ; Petridou J; Jagusch H; Astfalk N; Scheuring S; Schwarz S J Antimicrob Chemother; 2002 Apr; 49(4):611-7. PubMed ID: 11909834 [TBL] [Abstract][Full Text] [Related]
76. Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes. Pankuch GA; Lin G; Appelbaum PC Clin Microbiol Infect; 2005 Dec; 11(12):1040-4. PubMed ID: 16307562 [TBL] [Abstract][Full Text] [Related]
77. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline. Rolain JM; Lambert F; Raoult D Ann N Y Acad Sci; 2005 Dec; 1063():252-6. PubMed ID: 16481522 [TBL] [Abstract][Full Text] [Related]
78. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis. Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrel KL; Fernandez H Antimicrob Agents Chemother; 2003 Jun; 47(6):1963-7. PubMed ID: 12760875 [TBL] [Abstract][Full Text] [Related]
79. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901 [TBL] [Abstract][Full Text] [Related]
80. Bacteremia caused by Corynebacterium amycolatum with a novel mutation in gyrA gene that confers high-level quinolone resistance. Yoon S; Kim H; Lee Y; Kim S Korean J Lab Med; 2011 Jan; 31(1):47-8. PubMed ID: 21239871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]